BLISSGVS.NS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (9 May 2024 @ 03:06):

Stats
Today's Volume	131 809
Average Volume	674 287
Market Cap	11.67B
EPS	INR0 ( 2024-05-08 )
Next earnings date	( INR0 ) 2024-07-30
Last Dividend	INR0.500 ( 2023-07-12 )
Next Dividend	INR0 ( N/A )
P/E	13.43
ATR14	INR0.0650 (0.06%)

Volume Correlation

Long: 0.07 (neutral)

Short: -0.25 (neutral)

Signal:(40.643) Neutral

Bliss GVS Pharma Limited Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Bliss GVS Pharma Limited Correlation - Currency/Commodity

0.71
( moderate )

0.70
( moderate )

0.82
( strong )

0.67
( moderate )

-0.76
( moderate negative )

-0.82
( strong negative )

Bliss GVS Pharma Limited Financials

Annual	2022
Revenue:	INR7.52B
Gross Profit:	INR3.50B (46.60 %)
EPS:	INR6.83

FY	2022
Revenue:	INR7.52B
Gross Profit:	INR3.50B (46.60 %)
EPS:	INR6.83

FY	2022
Revenue:	INR7.38B
Gross Profit:	INR3.47B (47.02 %)
EPS:	INR2.24

FY	2021
Revenue:	INR5.69B
Gross Profit:	INR2.40B (42.16 %)
EPS:	INR6.64

Financial Reports:

No articles found.

Bliss GVS Pharma Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0.500 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Bliss GVS Pharma Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 4.34 - low (44.24%) | Divividend Growth Potential Score: 4.25 - Stable (14.92%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.300	2010-11-25
Last Dividend	INR0.500	2023-07-12
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	19	--
Total Paid Out	INR9.35	--
Avg. Dividend % Per Year	0.46%	--
Score	2.17	--
Div. Sustainability Score	4.34
Div.Growth Potential Score	4.25
Div. Directional Score	4.30	--

Next Divdend (Est)
(2024-12-10)

INR0.496 Estimate 3.25 %

Dividend Stability

0.26 Very Poor

Dividend Score

2.17

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR1.000	0.48%
2019	INR1.000	0.61%
2020	INR0.500	0.34%
2021	INR1.000	0.49%
2022	INR1.000	0.96%
2023	INR0.500	0.69%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
RALLIS.NS	Dividend Junior	2023-05-30	Annually	23	0.94%
KIRLOSIND.NS	Dividend Junior	2023-08-03	Annually	17	0.72%
ENDURANCE.NS	Dividend Junior	2023-08-10	Annually	8	0.30%
ALBERTDAVD.NS	Dividend Junior	2023-08-02	Annually	8	1.24%
SUTLEJTEX.NS	Dividend Junior	2023-08-18	Annually	18	1.03%
NCLIND.NS	Dividend Junior	2023-09-15	Semi-Annually	18	1.25%
ICEMAKE.NS	No Dividend Player	2023-09-14	Annually	7	0.81%
CDSL.NS	Dividend Knight	2023-08-25	Annually	7	0.92%
RUBYMILLS.NS	Dividend Junior	2023-09-20	Annually	23	0.96%
LIKHITHA.NS	Dividend Junior	2023-09-20	Annually	4	0.46%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.116	1.500	7.68	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.129	1.500	9.68	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	12.33	1.000	6.54	6.54	[3 - 30]
operatingCashFlowPerShareTTM	2.70	2.00	9.10	10.00	[0 - 30]
freeCashFlowPerShareTTM	2.70	2.00	8.65	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.477	1.000	5.38	5.38	[0.2 - 0.8]
operatingProfitMarginTTM	0.165	1.000	8.69	8.69	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				4.34

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	13.46	1.000	8.74	0	[1 - 100]
returnOnEquityTTM	0.129	2.50	9.79	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	2.70	2.00	9.10	10.00	[0 - 30]
dividendYielPercentageTTM	0.442	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	2.70	2.00	9.10	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.0366	1.500	-3.09	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0373	1.000	-1.566	0	[0.1 - 0.5]
Total Score				4.25

Bliss GVS Pharma Limited

Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company also provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syrups, and vaginal washes. In addition, it offers therapeutic products consisting of anti-bacterial, anti-dandruff shampoo, amino acid preparation, iron tonic, antitussive, appetite stimulant, anti-allergic, body supplement, anti-biotic, anti-diabetic, anti-diarrheal, anti-emetic, anti-fungal, anti-haemorrhoidal, anti-helmintic, anti-infective, anti-inflammatory, anti-malarial, anti-microbial, anti-migraine, anti-oxidant, anti-protozoal, ear wax solvent, anti-pyretic, anti-septic, anti-spasmodic, anti-ulcer, and anti-ulcerant; and analgesic, oral rehydration, antacid, anxiolytic, appetizer, cough syrup, erectile dysfunction, haematinic, hand sanitizer, health supplement, insecticide, laryngitis, pharyngitis, laxative, lubricant, mosquito repellant, nasal decongestant, nutritional supplement, moisturizer, prickly heat powder, skin lightening lotion, vaginal contraceptive, vaginal hygiene, and vitamin supplements, as well as medicated, complexion, moisturizing, and total protection soaps. The company also exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.